MX9801091A - Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion. - Google Patents

Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion.

Info

Publication number
MX9801091A
MX9801091A MX9801091A MX9801091A MX9801091A MX 9801091 A MX9801091 A MX 9801091A MX 9801091 A MX9801091 A MX 9801091A MX 9801091 A MX9801091 A MX 9801091A MX 9801091 A MX9801091 A MX 9801091A
Authority
MX
Mexico
Prior art keywords
cyclosporin
interleukin
combined use
immunosuppression therapy
combination
Prior art date
Application number
MX9801091A
Other languages
English (en)
Other versions
MXPA98001091A (es
Inventor
Waleed Tadmori
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority claimed from PCT/US1996/012538 external-priority patent/WO1997005896A1/en
Publication of MXPA98001091A publication Critical patent/MXPA98001091A/es
Publication of MX9801091A publication Critical patent/MX9801091A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una combinacion de interleukina-10 y ciclosporina se utiliza para suprimir la enfermedad injerto contra hospedero, las enfermedades autoinmunes y el rechazo de tejido/injerto. Se ha descubierto que la administracion de una combinacion de interleukina 10 y ciclosporina provoca la supresion sinérgica de la proliferacion de las células T. El uso concurrente de ambos agentes evita la toxicidad asociada con dosis superiores de ciclosporina.
MX9801091A 1995-08-09 1996-08-06 Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion. MX9801091A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US207795P 1995-08-09 1995-08-09
US002057 1995-08-09
US61996896A 1996-03-20 1996-03-20
US619968 1996-03-20
PCT/US1996/012538 WO1997005896A1 (en) 1995-08-09 1996-08-06 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy

Publications (2)

Publication Number Publication Date
MXPA98001091A MXPA98001091A (es) 1998-04-01
MX9801091A true MX9801091A (es) 1998-04-30

Family

ID=39426671

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801091A MX9801091A (es) 1995-08-09 1996-08-06 Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion.

Country Status (1)

Country Link
MX (1) MX9801091A (es)

Similar Documents

Publication Publication Date Title
HUS1400034I1 (hu) Dialkil-fumarátok alkalmazása autoimmun betegségek kezelésére szolgáló gyógyászati készítmények elõállítására
HK1049849A1 (en) Depsipeptide and congeners thereof for use as immunosuppressants.
IL104880A (en) Pharmaceutical composition comprising antigen for autoimmune diseases suppression
ZA944347B (en) The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
CA2229282A1 (en) Use of hyaluronic acid as an immunosuppressant
EP0663835A1 (en) USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY PROBLEMS.
KR910700055A (ko) 췌장염 및 췌장 이식시 면역 거부 반응 치료용 s-아데노실-메티오닌
RU98101907A (ru) Терапевтические агенты и аутоимунные заболевания
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
MX9801091A (es) Uso combinado de interleukina-10 y ciclosporina para terapia de inmunosupresion.
CA2385312A1 (en) Compositions and methods for preventing and treating transplant rejection
WO1997005896B1 (en) Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
HK1045456A1 (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
IL131478A0 (en) Methods for treatment of scar tissue
EP0668771A4 (en) TREATMENT OF AUTOIMMUNE DISEASES BY TOLERANCE IN CELLS, TISSUES AND ORGANS.
WO2001008696A3 (en) Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
EP0326067A3 (en) Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
Wong et al. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study
EP0697876A4 (en) THYMUS OF A XENOGRAFT
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
AU1367797A (en) Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy
CA2027842A1 (en) Treatment for multiple sclerosis with lymphocytapheresis and chemo-immunosuppression
KR900001369A (ko) 면역억제를 위한 이멕손의 사용 및 이멕손을 함유하는 제약조성물
UA27752C2 (uk) Похідні рапаміцину, що мають індукуючу імунодепресію активність, спосіб індукування імунодепресії, фармацевтична композиція